| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |